New drug combo tested for Tough-to-Treat breast cancer
NCT ID NCT05458674
Summary
This study is testing whether combining three existing drugs—tucatinib, trastuzumab, and eribulin—is safe and effective for people with advanced HER2+ breast cancer that has continued to grow despite previous treatments. It will enroll about 30 adults to see if this combination can shrink tumors and control the disease, including cancer that may have spread to the brain. The main goals are to check for side effects and see how well the treatment works.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for BREAST CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Cancer Care Northwest
RECRUITINGSpokane Valley, Washington, 99216, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
-
George Washington Medical Faculty Associates
RECRUITINGWashington D.C., District of Columbia, 20037, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
-
New Mexico Cancer Care Alliance
RECRUITINGAlbuquerque, New Mexico, 87131, United States
Contact Email: •••••@•••••
Contact
-
Swedish Cancer Institute
RECRUITINGIssaquah, Washington, 98029, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
-
University of Colorado
RECRUITINGAurora, Colorado, 80045, United States
Contact
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
University of Wisconsin Carbone Cancer Center
RECRUITINGMadison, Wisconsin, 53792, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
Conditions
Explore the condition pages connected to this study.